Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
551.43
508.03
555.42
499.33
464.71
455.02
560.73
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
551.43
508.03
555.42
499.33
464.71
455.02
560.73
Raw Material Cost
378.36
352.62
393.20
352.75
325.18
324.95
374.90
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.65
0.62
0.00
9.86
12.97
13.69
14.29
Selling and Distribution Expenses
66.78
62.61
84.84
60.53
49.94
45.56
55.48
Other Expenses
2.81
2.70
2.76
1.88
1.16
0.56
0.19
Total Expenditure (Excl Depreciation)
473.84
442.86
505.66
441.91
399.68
389.84
446.57
Operating Profit (PBDIT) excl Other Income
77.6
65.19999999999999
49.800000000000004
57.400000000000006
65
65.19999999999999
114.2
Other Income
-3.81
2.68
14.29
17.68
18.25
12.12
39.50
Operating Profit (PBDIT)
98.27
91.39
117.46
87.51
95.75
87.81
152.11
Interest
0.65
0.62
0.00
9.86
12.97
13.69
14.29
Exceptional Items
2.93
1.73
-1.21
2.32
0.70
-1.14
-2.22
Gross Profit (PBDT)
173.07
155.42
162.22
146.58
139.53
130.06
185.82
Depreciation
39.42
39.42
37.31
37.31
34.74
34.74
34.93
Profit Before Tax
61.14
53.08
78.95
42.66
48.75
38.24
100.68
Tax
10.44
3.91
9.03
1.07
11.62
2.15
13.15
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
50.56
48.89
70.34
40.89
36.71
35.79
87.75
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
50.56
48.89
70.34
40.89
36.71
35.79
87.75
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
50.56
48.89
70.34
40.89
36.71
35.79
87.75
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
4,565.71
5,498.73
6,300.14
7,149.00
3,626.37
3,024.23
2,987.55
Earnings per share (EPS)
0.22
0.21
0.32
0.2
0.18
0.18
0.44
Diluted Earnings per share
0.22
0.21
0.32
0.2
0.18
0.18
0.44
Operating Profit Margin (Excl OI)
11.37%
9.7%
11.86%
6.51%
9.2%
9.0%
13.85%
Gross Profit Margin
18.24%
18.21%
20.93%
16.02%
17.97%
16.04%
24.18%
PAT Margin
9.17%
9.62%
12.67%
8.19%
7.9%
7.87%
15.65%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2026 is 8.54% vs -8.53% in Mar 2026
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is 3.48% vs -30.44% in Mar 2026
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2026 is 15.11% vs -14.05% in Mar 2026
Interest
QoQ Growth in quarter ended Jun 2026 is 0.00% vs 0.00% in Mar 2026
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
Compare Quarterly Results Of PharmaBlock Sciences (Nanjing), Inc. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
551.43
0
551.43
Other Operating Income
0.00
0.00
0.00
Total Operating income
551.43
0
551.43
Raw Material Cost
378.36
0
378.36
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.65
0
0.65
Selling and Distribution Expenses
66.78
0
66.78
Other Expenses
2.81
0.00
2.81
Total Expenditure (Excl Depreciation)
473.84
0
473.84
Operating Profit (PBDIT) excl Other Income
77.58
0.00
77.58
Other Income
-3.81
0
-3.81
Operating Profit (PBDIT)
98.27
0
98.27
Interest
0.65
0
0.65
Exceptional Items
2.93
0
2.93
Gross Profit (PBDT)
173.07
0
173.07
Depreciation
39.42
0
39.42
Profit Before Tax
61.14
0
61.14
Tax
10.44
0
10.44
Provisions and contingencies
0
0
0.00
Profit After Tax
50.56
0
50.56
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
50.56
0
50.56
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
50.56
0
50.56
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
4,565.71
0
4,565.71
Earnings per share (EPS)
0.22
0
0.22
Diluted Earnings per share
0.22
0
0.22
Operating Profit Margin (Excl OI)
11.37%
0%
0.00
11.37%
Gross Profit Margin
18.24%
0%
0.00
18.24%
PAT Margin
9.17%
0%
0.00
9.17%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 55.14 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 8.54% vs -8.53% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 18.66% vs 26.48% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 5.06 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 3.48% vs -30.44% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 37.87% vs -25.41% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 10.21 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 15.11% vs -14.05% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 31.74% vs 16.54% in Jun 2025
Quarterly - Interest
Interest 0.06 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 0.00% vs 0.00% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -95.38% vs -13.33% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.37%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Footer loading
